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The hemagglutinin-neuraminidase (HN) glycoprotein of Newcastle disease virus was isolated by cleaving HN (cHN) from
reconstituted virosome with chymotrypsin. N-terminal sequence analysis of the purified cHN showed that chymotrypsin
cleavage had occurred at amino acid 123, freeing the C-terminal 454 amino acids. The purified cHN retained its neuramin-
idase and receptor binding activities and reacted with specific monoclonal antibodies, showing that the isolated cHN was
biologically and antigenically functional. The crystals of the cHN were obtained in acetate buffer (pH 4.6) containing
polyethylene glycol 3350 and ammonium sulfate and belong to the orthorhombic space group P212121 with unit cell
dimension of approximately a 5 72 Å, b 5 78 Å, and c 5 198 Å. Crystals of cHN grown in the presence of sialic acid (Neu5Ac)
were grown in HEPES buffer (pH 6.2) containing polyethylene glycol 3350 and belong to the hexagonal space groups P61 or
P65 with unit cell dimensions of a 5 b 5 137.5 Å and c 5 116.6Å. The orthorhombic crystals produced in this study diffract
X rays to at least 2.0-Å resolution, thereby setting the stage for the solution of the three-dimensional structure of the HN
glycoprotein of a paramyxovirus. © 2000 Academic PressINTRODUCTION
Paramyxovirus hemagglutinin-neuraminidase (HN) is
a multifunctional glycoprotein that plays a central role in
viral infection. It is responsible for the virus attachment to
sialic acid-containing host cell receptors (Markwell,
1991) and has neuraminidase (sialidase) activity to hy-
drolyze sialic acid residues, which is likely to function to
prevent virus self-aggregation and efficient virus spread
by analogy to the role of influenza virus neuraminidase
(Palese et al., 1974; Liu and Air, 1993). HN is also required
or membrane fusion that is induced by another surface
lycoprotein F (Morrison et al., 1991; Sakai and Shibuta,
989). Significant membrane fusion is observed only
hen HN and F proteins of the same virus or closely
elated viruses are expressed in the same cells, suggest-
ng that a virus-type-specific interaction is necessary for
he membrane fusion induced by the F protein (Horvath
t al., 1992; Hu et al., 1992). Experiments using chimeric
and mutated HN proteins indicate that the stalk region as
well as head region plays a role in the fusion promotion
activity (Bousse et al., 1994, 1995; Deng et al., 1995;
Tanabayashi and Compans., 1996; Tsurudome et al.,
1998). A physical interaction between HN and F is re-
ported to be required for efficient membrane fusion (Yao
et al., 1997; Stone-Hulslander and Morrison, 1997). Cir-
cular dichroism studies revealed that the conformation of1 To whom reprint requests should be addressed. Fax: (901) 523-
622. E-mail: allen.portner@stjude.org.
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208the viral glycoproteins in vesicles formed by co-reconsti-
tution of the HN and F glycoproteins is different from that
of the conformation of these glycoproteins in either HN
or F vesicles or in a mixture of both, suggesting that the
viral envelope glycoproteins possess a certain confor-
mation that exists only when they are present within the
same membrane (Citovsky et al., 1986).
The nucleic acid sequence of the paramyxovirus HN
genes predicts a three-domain HN structure: a large
hydrophilic carbohydrate-containing domain external to
the viral membrane, a small hydrophobic domain span-
ning the membrane, and a small hydrophilic domain
internal to the membrane (Morrison and Portner, 1991;
Sakaguchi et al., 1989). The large hydrophilic domain
contains the functional sites for cell attachment and
neuraminidase activity, as well as the antigenic sites
recognized by monoclonal antibodies (MAbs). It is not
known whether HN molecule contains combined or sep-
arate active sites for hemagglutinin and neuraminidase
activities. However, the preponderance of evidence sug-
gests that cell-binding and neuraminidase activities oc-
cur at separate sites (Portner, 1981; Portner et al., 1987).
Most paramyxovirus HNs form disulfide-linked dimers. In
Newcastle disease virus (NDV) HN, a cysteine residue at
123 was identified to be responsible for the disulfide-
linked dimer formation (Sheehan et al., 1987).
Despite the importance of the diseases caused by
paramyxoviruses, the crystallization and subsequent
analysis of three-dimensional structure of the HN have
not been successful. This structure will advance our
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209CRYSTALLIZATION OF NDV HN GLYCOPROTEINunderstanding by providing a structural interpretation of
how HN binds to a sialic acid-containing receptor on
target cell to initiate the virus–cell interaction, how HN
plays a role in the fusion process, and how the neur-
aminidase removes sialic acid from carbohydrates, facil-
itating the release of progeny virus from infected cells.
Previously, we produced rectangular crystals of the HN
protein of human parainfluenza virus type-1 (hPIV1) that
diffracted X rays weakly to approximately 10 Å (Takimoto
et al., 1992). Here, we report the first successful crystal-
ization of the HN protein of NDV that diffract X rays to a
esolution beyond 2.0 Å, thereby allowing the determina-
ion of the three-dimensional atomic structure of HN.
RESULTS AND DISCUSSION
Isolation and purification of a soluble form of the HN
glycoprotein
Paramyxovirus HN is a type II membrane glycopro-
tein, which is anchored in the viral envelope by a
stretch of hydrophobic amino acids near its N termi-
nus. To isolate soluble proteins that are suitable for
crystallization, the hydrophobic membrane-spanning
region is required to be enzymatically removed
(Thompson et al., 1988; Takimoto et al., 1992; Varghese
et al., 1983; Wilson et al., 1981). NDV strain Kansas
grown in embryonated eggs was purified and sub-
jected to digestion with various proteases. Direct in-
cubation of purified NDV with proteases such as Pro-
nase, trypsin, chymotrypsin, or bromelein was not suc-
cessful in the isolation of soluble HN molecule (data
not shown). It has been reported that NDV HN isolated
from virions by detergent was susceptible to chymo-
trypsin cleavage, suggesting that chymotrypsin was
unable to approach its target site on HN when at-
tached to the virion, probably because of its tight
oligomer formation or interaction with F proteins.
Therefore, as an alternative, we isolated membrane
proteins by disrupting virus with Triton X-100 and re-
constituted virosomes containing membrane proteins.
After sedimentation of the ribonucleoprotein complex,
the supernatant containing viral membrane proteins
with lipids and Triton X-100 was isolated. Virosomes
containing the membrane proteins were reconstituted
from the supernatant by withdrawing the detergent
using Bio-Beads (Fig. 1, lane 1). To isolate HN, recon-
stituted virosomes, which contain HN, F, and M pro-
teins, were treated with chymotrypsin at 500 mg/mL
Fig. 1, lane 2). Solution containing cHN was purified
y filtration through Centricon 100, which resulted in
he preparation of pure concentrated cHN (Fig. 1, lane
). The cHN migrated as a monomer when analyzed by
DS–PAGE under nonreducing condition (data not
hown), suggesting that the cHN did not form disul-
ide-linked oligomers. sloning and sequence of NDV Kansas HN cDNA
To obtain the protein sequence of NDV strain Kansas
N and to characterize the functions of the protein, a
DNA clone of the HN gene of NDV Kansas strain was
onstructed by reverse transcription–polymerase chain
eaction (RT–PCR) from mRNA isolated from NDV-in-
ected cells. Primers used for PCR were synthesized
rom the information of other NDV strain HN genes se-
uenced previously (Sakaguchi et al., 1989). The con-
tructed cDNA was cloned into vector pTF1 at HindIII
nd KpnI sites. Sequencing of the cDNA indicated that
he HN gene encodes a protein of 577 amino acids with
ix potential glycosylation sites (Fig. 2). The molecular
ass of unglycosylated HN is predicted to be 63,069 Da
rom sequence data. Sequence comparison with other
ublished strains (Sakaguchi et al., 1989) indicates that
ansas strain is most closely related to strain Beaudette
(99% homologous). A previous report showed that the
ysteine residue 123 was responsible for the formation
f disulfide-linked dimers in some strains of HN (Shee-
an et al., 1987). SDS–PAGE analysis under reducing and
onreducing conditions showed that the Kansas HN
oes not form disulfide-linked dimers. Sequence analy-
is of strain Kansas indicated that this strain has Trp
nstead of Cys at position 123.
-terminal sequence analysis of c-HN
To identify the precise cleavage site, we sequenced
he N-terminal amino acids of the cHN by automated
dman degradation. The sequence obtained was GAPI-
DPDFIGGIGK. By comparison with the complete pro-
ein sequence predicted from NDV HN cDNA, we found
hat chymotrypsin cleaved the HN molecule at the site
etween Trp123 and Gly124 (Fig. 2). This result con-
irmed that the cHN no longer contained the hydrophobic
nchor region (residues 27–50) and was consistent with
he migration of the cHN on SDS–PAGE.
iological activities of cHN
FIG. 1. SDS–PAGE analysis of the cleaved HN stained by Coomassie
brilliant blue staining. Lane 1, reconstituted virosome; lane 2, virosome
treated with chymotrypsin; and lane 3, purified cHN; 4, purified NDV.We characterized the cHN to ensure it retains the
tructure and functions of intact HN protein. Neuramini-
avage
210 TAKIMOTO ET AL.dase activity of cHN was measured and compared with
the intact HN protein on purified virus. The neuramini-
dase activity of the purified cHN (A549–0.949) was almost
identical to that of the same amount (3 mg) of intact HN
protein (A549–0.961), establishing that cleavage and puri-
fication had not altered the level of NA function. Receptor
binding activity of the cHN was determined by the hem-
agglutination inhibition test. Our results indicated that
chicken red blood cells preincubated with more than 3
mg/ml cHN were not agglutinated by 4 HA units of puri-
fied NDV, showing that the cHN retains the receptor
binding activity and blocked all the receptors on the red
blood cells. Further evidence that the cHN retained its
native structure was the ability of cHN to bind conforma-
tionally sensitive MAbs to the same extent as intact HN
(data not shown).
Crystallization of cHN
Crystallization of the cHN was carried out using vapor
diffusion in hanging drops. We obtained a number of
different crystal forms, including bipyramidal and rhom-
boid (Fig. 3A), in a precipitant that contains polyethylene
glycol (PEG) 3350 and 0.2 M ammonium sulfate in 0.1 M
citrate buffer (pH 4.6). Crystals varied in size, but the
largest grew to maximum dimensions of 0.5 3 0.2 3 0.3
mm. The crystals were washed, dissolved in PBS, and
analyzed by SDS–PAGE. We detected a strong band of
protein that migrated to the position of purified cHN on
SDS–PAGE, showing that the crystals were made of cHN.
FIG. 2. Predicted amino acid sequence of HN protein of NDV stra
glycosylation sites are underlined. The arrow shows chymotrypsin cleIn addition, cHN from the dissolved crystals retained
neuraminidase activity (data not shown).To obtain crystals of a putative cHN–sialic acid com-
plex, we incubated the cHN (12 mg/ml) with sialic acid at
the final concentration of 10 mM. The complex crystal-
lized in a precipitant that contained 20% PEG 3350 in 0.1
as. Predicted transmembrane region is shown in bold. Six potential
site on HN.
FIG. 3. Crystals of NDV cHN (A) and cHN-Neu5Ac complex (B).in KansBipyramidal and rhomboid crystals were grown from solutions of
PEG3350. Maximum dimensions of these crystals were 0.2–0.5 mm.
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211CRYSTALLIZATION OF NDV HN GLYCOPROTEINM HEPES buffer (pH 6.2 or 6.4). cHN alone would not
form crystals under similar conditions, suggesting that
some conformational changes were induced by complex
formation with sialic acid. The crystals grew as hexago-
nal pyramids or a combination of hexagonal prisms and
pyramids (Fig. 3B).
X-ray diffraction analysis
The pH 4.6 cHN crystals diffracted to about 2.7 Å on
the in-house X-ray source and to beyond 2.0 Å on the
synchrotron source (Fig. 4A). The crystals belong to the
orthorhombic space group P212121 as judged by system-
atically absent axial reflections. The asymmetric unit is
likely to contain a dimer of 50-kDa monomers, as this
gives a solvent content of 57%; however, a self-rotation
function did not reveal any obvious noncrystallographic
symmetry axis (Fig. 5A). The crystals were protected with
10% glycerol (v/v) added to the crystallization buffer be-
fore flash freezing in a N2 gas stream at 100 K. The
utative cHN–sialic acid complex crystals belong to the
pace group P61 or its enantiomorph P65, as judged by
ystematically absent reflections. The crystals diffracted
o 2.7 Å at the synchrotron and were cryoprotected by
ipping the crystals into crystallization solution contain-
ng 20% glycerol (v/v) (Fig. 4B). Table 1 gives the data
ollection statistics. The asymmetric unit is again likely
o contain two monomers, giving a solvent content of
2%, and the self-rotation function reveals a noncrystal-
FIG. 4. Diffraction from a 0.5-degree rotation of crystals of cHN obtain
form where the edge of the diffraction pattern corresponds to 1.98-Å r
the edge of the diffraction pattern corresponds to 2.65-Å resolution.ographic twofold normal to the sixfold screw axis (Fig.
B).
2
toncluding remarks
This study is the first report of the crystallization of a
aramyxovirus HN that diffracts X rays to a high resolu-
ion (,2.0 Å), thereby setting the stage for the solution of
he HN three-dimensional structure. The determination
f the HN structure at atomic resolution is likely to
rovide new insights into the antigenic structure of HN
nd the molecular mechanism of virus attachment, entry,
nd release. In addition, knowledge of the HN structure
hould provide a stimulus for future investigation and
uggest strategies for the development of antiviral drugs
hat prevent and/or ameliorate paramyxovirus infections.
MATERIALS AND METHODS
iruses and cells
NDV was grown in 10-day-old chick embryos and
urified by sucrose density gradient centrifugation (Port-
er et al., 1975). Baby hamster kidney (BHK) cells were
aintained in Dulbecco’s modified Eagle’s medium with
% fetal calf serum.
econstitution of virosome and isolation of
roteolytically cleaved HN
Membrane proteins were isolated by treatment of pu-
ified NDV with 1% Triton X-100 in PBS. Insoluble mate-
ials were sedimented by centrifugation at 35,000 rpm for
synchrotron beamline X11 at DESY, Hamburg. (A) Orthorhombic crystal
n. (B) Hexagonal crystal form of the cHN–sialic acid complex, whereed onh at 4°C in a Beckman SW55 rotor. Supernatant con-
aining membrane proteins were collected, and Triton
s of inte
allogra
212 TAKIMOTO ET AL.X-100 was removed by incubation with Bio-Beads SM-2
Adsorbent (Bio-Rad, Hercules, CA), which resulted in the
reconstitution of virosomes containing membrane pro-
teins. The virosomes were incubated with chymotrypsin
(0.5 mg/ml) overnight at room temperature. TPCK (60
mg/ml) was added to terminate chymotrypsin digestion,
and the soluble cHN was separated from virosome by
ultracentrifugation at 37,000 rpm for 2 h at 4°C in a
Beckman SW55 rotor. The cHN in the supernatant was
further purified and concentrated by filtration through
Centricon-100 (Amicon).
Cloning and sequencing of HN gene
Cloning of NDV HN cDNA was performed by RT–PCR.
Briefly, mRNAs were isolated from NDV-infected BHK
FIG. 5. Self-rotation function plots. Stereographic projections of the k
data within the resolution range of 8–4 Å was used, with a 20-Å radiu
form showing clear noncrystallographic twofold axes normal the cryst
T
X-ray Data C
Dataset Native 1
Temperature (K) 293
Space group P212121
Unit cell (Å), a, b, c 73.3, 78.0, 202.6
Resolution (Å) 3.0
No. of observations 172104
No. unique 20022
Rmerg (%) 9.3
Completeness (%) 83Note. Rmerg 5 Shkl S iuS Ihkli 2 ^Ihkl&/S hkl S i ^Ihkli &, where the sum i is overall s
temperature native collected in-house. Native 2 and the putative sialic acid ccells and then reverse transcribed into cDNA by avian
myoblastosis virus reverse transcriptase. The cDNA was
subject to PCR amplification using NDV HN-specific
primers that hybridize the 59 and 39 noncoding regions of
the HN gene. The primers were designed from the se-
quence information published previously (Sakaguchi et
al., 1989). The specific primers include unique restriction
sites HindIII and KpnI, respectively. The NDV HN cDNA
was subcloned into vector plasmid pTF1 at HindIII and
KpnI sites (Takahashi et al., 1992). The cloned HN cDNA
was sequenced by the dideoxy chain termination method
using the Sequenase version 2.0 T7 DNA polymerase
(Amersham Life Science). The sequence of the NDV
Kansas HN gene described here was deposited in Gen-
Bank under Accession No. AF212323.
egrees section, showing the orientation of twofold axes. In both cases,
gration. (A) The orthorhombic crystal form. (B) The hexagonal crystal
phic sixfold screw axis at f 5 21, 51, 81, 111, 141, and 171 degrees.
n Statistics
Native 2 Sialic acid complex
100 100
P212121 P61/P65
72.3, 77.9, 199.2 137.7, 137.5, 116.6
2.0 2.7
623166 498619
68217 38673
4.9 5.2
86 945 180 dABLE 1
ollectioeparate measurements of the unique reflections hkl. Native 1 is room
omplex were collected at the Hamburg synchrotron.
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213CRYSTALLIZATION OF NDV HN GLYCOPROTEINCharacterization of the cHN
The N-terminal sequence of cHN was determined by
automated Edman degradation on a gas-phase se-
quencer (Applied Biosystems). Neuraminidase activity of
cHN was determined according to the method of Aminoff
(1961). Cell binding activity of cHN was assayed by
inhibitory effect of cHN to hemagglutination by intact
virus. Purified cHN was incubated with cRBC at 4°C for
1 h, and then 4 HA units of intact virus (NDV) were added
to the mixture. After 1-h incubation at 4°C, the hemag-
glutination inhibition was measured. Reactivity of cHN
with MAbs sensitive to the HN structure was determined
by enzyme-linked immunosorbent assay (Portner et al.,
987)
rystallization procedure
Vapor-diffusion crystallization was performed in hang-
ng drops. An equal mixture of cHN (10 mg/ml) and
recipitant (25% PEG 3350, 200 mM ammonium sulfate,
00 mM citrate buffer, pH 4.6) was drop-suspended on a
lass plate over the precipitant. For the crystallization of
he putative cHN–sialic acid complex, 9 volumes of cHN
12 mg/ml) were incubated with 1 volume of 100 mM
eu5Ac (Sigma) at room temperature for 1 h and then
rystallized as described earlier. We used 20% PEG 3350
n 0.1 M HEPES buffer (pH 6.2) as precipitant.
-ray diffraction analysis
X-ray diffraction data were collected from cHN crystals
ither at room temperature, using quartz capillary
ounts, or at 100 K, using crystals mounted in cryo-loops
ith a suitable cryoprotectant to avoid icing. Data were
ollected on in-house rotating anode sources operating
ypically at 50 kV and 100 mA or at beamline X11 at DESY
Hamburg, Germany) using image plate detectors. Data
ere processed using the HKL (Otwinowski and Minor,
997) data reduction package. Self-rotation functions
ere calculated using the GLRF software package (Tong
nd Rossman, 1997).
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